NCT03294694 2025-05-31Ribociclib + PDR001 in Breast Cancer and Ovarian CancerDana-Farber Cancer InstitutePhase 1 Terminated33 enrolled
NCT04802876 2025-03-21ACROPOLISOLTI Breast Cancer Research GroupPhase 2 Active not recruiting184 enrolled